(Q46100504)

19 December 2017

title

MK-801, an excitatory amino acid antagonist, does not improve neurologic outcome following cardiac arrest in cats (English)

1 reference

19 December 2017

1 reference

Fleischer JE

1

1 reference

19 December 2017

Tateishi A

2

1 reference

19 December 2017

Drummond JC

3

1 reference

19 December 2017

Scheller MS

4

1 reference

19 December 2017

Grafe MR

5

1 reference

19 December 2017

Zornow MH

6

1 reference

19 December 2017

Shearman GT

7

1 reference

19 December 2017

Shapiro HM

8

1 reference

19 December 2017

publication date

1 December 1989

1 reference

19 December 2017

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

19 December 2017

volume

9

1 reference

19 December 2017

issue

6

1 reference

19 December 2017

page(s)

795-804

1 reference

19 December 2017

Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

Cerebral blood flow and edema following carotid occlusion in the gerbil

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

Amino acid neurotransmitters and their pathways in the mammalian central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

Glutamate activates multiple single channel conductances in hippocampal neurons.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

Recirculation in the rat brain following incomplete ischemia.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

Communications between vertebro-basilar and carotid arterial circulations in the gerbil.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

Cerebral ATP and lactate levels in the squirrel monkey following occlusion of the middle cerebral artery.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

The Effects of Anesthesia and Hypothermia on Canine Cerebral ATP and Lactate during Anoxia Produced by Decapitation

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

Differential effects of competitive and non-competitive N-methyl-D-aspartate antagonists on glucose use in the limbic system

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

Lesions to Schaffer collaterals prevent ischemic death of CA1 pyramidal cells.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

Cerebral blood flow. A predictor of recovery from ischemia in the gerbil

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

Focal cerebral ischaemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischaemia

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

Glutamate and related acidic excitatory neurotransmitters: from basic science to clinical application.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

Glutamate and the pathophysiology of hypoxic--ischemic brain damage

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

MAC of sevoflurane in humans and the New Zealand white rabbit

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

Cerebral circulation and metabolism

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

The effects of 5-minute ischemia in Mongolian gerbils: I. Blood-brain barrier, cerebral blood flow, and local cerebral glucose utilization changes.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

Long-term development of selective neuronal loss and the mechanism of protection by 2-amino-7-phosphonoheptanoate in a rat model of incomplete forebrain ischaemia

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

Nimodipine does not improve neurologic outcome after 14 minutes of cardiac arrest in cats

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

The neurologic effects of thiopental therapy following experimental cardiac arrest in cats.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

Evidence for amelioration of ischaemic neuronal damage in the hippocampal formation by lesions of the perforant path.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1989.113

7 January 2021

Identifiers

DOI

10.1038/JCBFM.1989.113

1 reference

19 December 2017

1 reference

19 December 2017